Every month, ProMab features one of the latest publications in research that reference our products or custom antibody services. In the following publication, “Western blotting was performed with a primary antibody against purified partial LasAI (N-terminus, one repeat and part of the translocator domain) from an immunized mouse (ProMab Biotechnologies, Richmond, CA).”
To read the entire publication, you can visit the publication at PLOS ONE.
ProMab Biotechnologies develops and commercializes recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology, using novel high-throughput technologies. We offer a large range of products and services including a database of monoclonal antibodies, recombinant proteins, cancer stem cells, and custom antibody services such as custom monoclonal antibodies and protein expression services.